[go: up one dir, main page]

FI813539L - Maenniskans hybridleukosyt-interferoner - Google Patents

Maenniskans hybridleukosyt-interferoner

Info

Publication number
FI813539L
FI813539L FI813539A FI813539A FI813539L FI 813539 L FI813539 L FI 813539L FI 813539 A FI813539 A FI 813539A FI 813539 A FI813539 A FI 813539A FI 813539 L FI813539 L FI 813539L
Authority
FI
Finland
Prior art keywords
interferons
maenniskans
interferoner
hybridleukosyt
host organisms
Prior art date
Application number
FI813539A
Other languages
English (en)
Other versions
FI79550C (fi
FI79550B (fi
Inventor
David Van Norman Goeddel
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/237,388 external-priority patent/US4414150A/en
Priority claimed from US06/305,657 external-priority patent/US4456748A/en
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of FI813539L publication Critical patent/FI813539L/fi
Application granted granted Critical
Publication of FI79550B publication Critical patent/FI79550B/fi
Publication of FI79550C publication Critical patent/FI79550C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI813539A 1980-11-10 1981-11-10 Foerfarande foer framstaellning av ett humant hybridleukocytinterferon. FI79550C (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US20557980A 1980-11-10 1980-11-10
US20557980 1980-11-10
US23738881 1981-02-23
US06/237,388 US4414150A (en) 1980-11-10 1981-02-23 Hybrid human leukocyte interferons
US30565781 1981-09-25
US06/305,657 US4456748A (en) 1981-02-23 1981-09-25 Hybrid human leukocyte interferons

Publications (3)

Publication Number Publication Date
FI813539L true FI813539L (fi) 1982-05-11
FI79550B FI79550B (fi) 1989-09-29
FI79550C FI79550C (fi) 1990-01-10

Family

ID=27394813

Family Applications (1)

Application Number Title Priority Date Filing Date
FI813539A FI79550C (fi) 1980-11-10 1981-11-10 Foerfarande foer framstaellning av ett humant hybridleukocytinterferon.

Country Status (34)

Country Link
EP (1) EP0051873B1 (fi)
JP (1) JP2642291B2 (fi)
KR (1) KR920007439B1 (fi)
AT (1) ATE46718T1 (fi)
AU (1) AU555293B2 (fi)
BR (1) BR8107293A (fi)
CA (2) CA1212915A (fi)
CH (2) CH663032A5 (fi)
DE (2) DE3144469A1 (fi)
DK (1) DK173590B1 (fi)
DO (1) DOP1981004064A (fi)
DZ (1) DZ350A1 (fi)
ES (2) ES506955A0 (fi)
FI (1) FI79550C (fi)
FR (1) FR2493867B1 (fi)
GB (1) GB2090258B (fi)
GR (1) GR81947B (fi)
HK (1) HK51685A (fi)
IE (1) IE51850B1 (fi)
IL (1) IL64243A (fi)
IT (1) IT1169276B (fi)
KE (1) KE3536A (fi)
LU (1) LU83745A1 (fi)
MC (1) MC1424A1 (fi)
MY (2) MY8700710A (fi)
NL (1) NL189092C (fi)
NO (1) NO165201C (fi)
NZ (1) NZ198906A (fi)
PH (1) PH18565A (fi)
PL (1) PL233748A1 (fi)
PT (1) PT73955B (fi)
SE (1) SE460539B (fi)
YU (1) YU46597B (fi)
ZW (1) ZW26981A1 (fi)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH657141A5 (de) * 1980-07-01 1986-08-15 Hoffmann La Roche Dns-sequenzen, rekombinante expressionsvektoren zur mikrobiellen herstellung von human-leukozyten-interferonen und transformierte mikroorganismen.
EP0085693A1 (en) * 1981-08-14 1983-08-17 A/S Alfred Benzon Subjects relating to human inteferon-alpha subtype proteins and corresponding antibodies
EP0072541A3 (en) * 1981-08-14 1984-04-18 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Human leukocyte interferons, process for their microbial production, intermediates therefor and compositions containing them
GB2108510B (en) * 1981-10-03 1984-12-12 Ciba Geigy Ag Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof
WO1983002461A1 (en) * 1982-01-19 1983-07-21 Cetus Corp Multiclass hybrid interferons
DE3220116A1 (de) * 1982-05-28 1983-12-01 Dr. Karl Thomae Gmbh, 7950 Biberach Mikrobiologisch hergestellte (alpha)- und ss-interferone, dna-sequenzen, die fuer diese interferone codieren, mikroorganismen, die diese genetische information enthalten, und verfahren zu ihrer herstellung
CA1252046A (en) * 1982-11-04 1989-04-04 Martin J. Cline Methods for oncogenic detection
WO1984003300A1 (fr) * 1983-02-24 1984-08-30 Inst Organicheskogo Sinteza Ak Interferon n humain leucocytaire et son procede d'obtention dans des cellules bacteriennes
GB8315980D0 (en) * 1983-06-10 1983-07-13 Biogen Nv Producing hybrid dna sequences
GB8317880D0 (en) * 1983-07-01 1983-08-03 Searle & Co Structure and synthesis of interferons
US4892743A (en) * 1983-12-21 1990-01-09 Schering Corporation Novel hybrid interferon species
EP0146903A3 (en) * 1983-12-19 1987-07-22 Schering Corporation Production of a vector encoding a novel hybrid interferon species
DE3409966A1 (de) * 1984-03-19 1985-09-26 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von human-gammainterferon und mittel zur durchfuehrung dieses verfahrens
JPS6156199A (ja) * 1984-08-27 1986-03-20 Shionogi & Co Ltd 新規ヒトインタ−フエロンα類
EP0173935A1 (en) * 1984-08-31 1986-03-12 University Patents, Inc. Hybrid lymphoblastoid-leukocyte human interferons
DE3434345A1 (de) * 1984-09-19 1986-03-27 Hoechst Ag, 6230 Frankfurt Verwendung von (alpha)-interferonen zur bekaempfung von durchfaellen
DE3685044D1 (de) * 1985-02-01 1992-06-04 Ici Plc Analoge interferon-polypeptide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
US4885166A (en) * 1985-06-11 1989-12-05 Ciba-Geigy Corporation Hybrid interferons
EP0240550A4 (en) * 1985-09-26 1989-09-19 Genetics Inst TENSIO-ACTIVE PULMONARY PROTEINS.
US4806347A (en) * 1985-12-11 1989-02-21 Schering Corporation Interferon combinations
EP0490233A1 (de) * 1986-03-10 1992-06-17 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Monoclonale Antikörper gegen BgIII-Hybridinterferone, deren Verwendung und Verfahren zu ihrer Herstellung
DE3607835A1 (de) * 1986-03-10 1987-09-24 Boehringer Ingelheim Int Hybridinterferone, deren verwendung als arzneimittel und als zwischenprodukte zur herstellung von antikoerpern und deren verwendung sowie verfahren zu ihrer herstellung
US4851220A (en) * 1986-11-26 1989-07-25 Schering Corporation Stable oleaginous gel
US4853218A (en) * 1987-02-24 1989-08-01 Schering Corporation Zinc-protamine-alpha interferon complex
EP0331635A3 (en) * 1988-02-29 1990-02-28 The Board of Regents of the University of Texas System Preparations for treating bladder cancer
US5372808A (en) † 1990-10-17 1994-12-13 Amgen Inc. Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect
GB2273931A (en) * 1992-09-28 1994-07-06 Unilever Plc Mutant polypeptides
JPH11507352A (ja) 1995-06-07 1999-06-29 ジンタ・インコーポレイテッド 新規カルバメート基本カチオン性脂質
TW442492B (en) * 1995-07-26 2001-06-23 Novartis Ag Process for the enrichment of interferon
FR2823220B1 (fr) 2001-04-04 2003-12-12 Genodyssee Nouveaux polynucleotides et polypeptides de l'erythropoietine (epo)
AU2003263552A1 (en) 2002-09-09 2004-03-29 Nautilus Biotech Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
US7314613B2 (en) 2002-11-18 2008-01-01 Maxygen, Inc. Interferon-alpha polypeptides and conjugates
BRPI0511196A (pt) 2004-05-19 2007-12-04 Maxygen Inc polipeptìdeo isolado ou recombinante, conjugado, composição, célula hospedeira, vetor, métodos para preparar um polipeptìdeo, para preparar um conjugado, para reduzir o número de cópias de um vìrus em células infectadas com o vìrus, para reduzir o nìvel de rna hcv, dna hbv e rna hiv no soro de um paciente infectado com hcv, hbv e hiv, e, uso do polipeptìdeo, do conjugado ou da composição
KR20080019619A (ko) 2005-05-18 2008-03-04 맥시겐, 인크. 개량된 인터페론-알파 폴리펩티드

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE54096B1 (en) * 1980-01-08 1989-06-21 Biogen Nv Dn sequences, recombinant dna molecules and processes for producing human interferon - like polypeptides

Also Published As

Publication number Publication date
DE3144469A1 (de) 1982-09-02
FI79550C (fi) 1990-01-10
BR8107293A (pt) 1982-08-03
AU555293B2 (en) 1986-09-18
ZW26981A1 (en) 1982-06-02
CH663032A5 (de) 1987-11-13
FR2493867A1 (fr) 1982-05-14
CA1212915A (en) 1986-10-21
PL233748A1 (en) 1983-07-18
IE51850B1 (en) 1987-04-15
ATE46718T1 (de) 1989-10-15
JPH07308191A (ja) 1995-11-28
ES8302778A1 (es) 1983-02-01
IT8124967A0 (it) 1981-11-10
NL8105078A (nl) 1982-06-01
NO165201B (no) 1990-10-01
FR2493867B1 (fr) 1986-06-27
ES512354A0 (es) 1983-03-01
IE812622L (en) 1982-05-10
EP0051873A3 (en) 1982-09-22
GR81947B (fi) 1984-12-12
JP2642291B2 (ja) 1997-08-20
MC1424A1 (fr) 1982-10-18
ES506955A0 (es) 1983-02-01
GB2090258B (en) 1984-05-02
NO165201C (no) 1991-01-16
AU7730481A (en) 1982-05-20
FI79550B (fi) 1989-09-29
DK173590B1 (da) 2001-04-02
MY8700710A (en) 1987-12-31
GB2090258A (en) 1982-07-07
NZ198906A (en) 1985-12-13
EP0051873B1 (en) 1989-09-27
PH18565A (en) 1985-08-09
YU265681A (en) 1984-08-31
CH660743A5 (de) 1987-06-15
LU83745A1 (de) 1983-09-01
IL64243A (en) 1985-11-29
DOP1981004064A (es) 1988-03-16
NL189092C (nl) 1993-01-04
NL189092B (nl) 1992-08-03
MY8800066A (en) 1988-12-31
IT1169276B (it) 1987-05-27
HK51685A (en) 1985-07-12
KR920007439B1 (ko) 1992-09-01
PT73955A (en) 1981-12-01
SE460539B (sv) 1989-10-23
YU46597B (sh) 1994-01-20
KR830007825A (ko) 1983-11-07
EP0051873A2 (en) 1982-05-19
DE3177106D1 (en) 1989-11-02
DZ350A1 (fr) 2004-09-13
KE3536A (en) 1985-06-07
NO813785L (no) 1982-05-11
PT73955B (en) 1983-11-23
ES8304200A1 (es) 1983-03-01
SE8106641L (sv) 1982-06-24
CA1277616C (en) 1990-12-11
DK494681A (da) 1982-05-11
IL64243A0 (en) 1982-02-28

Similar Documents

Publication Publication Date Title
FI813539L (fi) Maenniskans hybridleukosyt-interferoner
SE8105657L (sv) Mikrobiell framstellning av humanfibroblastinterferon
HK49285A (en) Interferons and process for their preparation
FI831818L (fi) Mikrobiologiskt framstaellda - och -interferoner, dessa interferoner kodande dna-sekvenser, dennagenetiska information innehaollande mikroorganismer och deras framstaellningsfoerfarande
ATE159297T1 (de) Expression von menschlichen serumalbumin in methylotrophischen hefen
FI90667C (fi) Menetelmä valmistaa uutta ihmisen tyypin I interferoniproteiinia
EP0072541A3 (en) Human leukocyte interferons, process for their microbial production, intermediates therefor and compositions containing them
EP0676413A3 (en) Interferon alpha / beta binding protein, its production and application.

Legal Events

Date Code Title Description
MA Patent expired

Owner name: GENENTECH, INC.